Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT06080802Phase 2/3Unknown
The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction
Diabete Type 2Heart Failure With Preserved Ejection Fraction
Studydirector

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

MSA university

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mai abdelhafez, PhD

MSA university

Related
1 trials

Shared therapeutic areas:

Diabete Type 2Heart Failure With Preserved Ejection Fraction

Worked with same sponsors:

clinical research unit, El-sheikh zayed specialized hospital - Egyptian Ministry of healthOctober University for Modern Sciences and Arts
Collaborated on 1 trial
Similarity Score24%

Barry Borlaug, MD

Mayo Clinic

Related
12 trials

Shared therapeutic areas:

Heart Failure With Preserved Ejection Fraction
Similarity Score15%

Michael E Widlansky, MD

Medical College of Wisconsin

Related
3 trials

Shared therapeutic areas:

Heart Failure With Preserved Ejection Fraction
Similarity Score15%

Norbert Frey, MD

University Hospital Heidelberg

Related
2 trials

Shared therapeutic areas:

Heart Failure With Preserved Ejection Fraction
Similarity Score15%

Mardi Gomberg-Maitland, MD

George Washington University

Related
3 trials

Shared therapeutic areas:

Heart Failure With Preserved Ejection Fraction
Similarity Score15%

Tariq Ahmad, MD MPH

Yale University

Related
3 trials

Shared therapeutic areas:

Heart Failure With Preserved Ejection Fraction
Similarity Score15%

David W. Wray, PhD

VA Salt Lake City Health Care System, Salt Lake City, UT

Related
4 trials

Shared therapeutic areas:

Heart Failure With Preserved Ejection Fraction
Similarity Score15%

Malte Kelm, Prof.

Clinic for Cardiology, Pneumology and Angiology at University Hospital Düsseldorf

Related
8 trials

Shared therapeutic areas:

Heart Failure With Preserved Ejection Fraction
Similarity Score15%

Ralph A DeFronzo, MD

University of Texas

Related
4 trials

Shared therapeutic areas:

Heart Failure With Preserved Ejection Fraction
Similarity Score15%

Michiel Rienstra, MD, PhD

University Medical Center Groningen

Related
3 trials

Shared therapeutic areas:

Heart Failure With Preserved Ejection Fraction
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06080802Phase 2/3StudyDirector

The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction

Diabete Type 2Heart Failure With Preserved Ejection Fraction
Unknown

All 1 trials loaded